Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
7.86
-1.33 (-14.47%)
At close: Feb 27, 2026, 4:00 PM EST
7.90
+0.04 (0.51%)
After-hours: Feb 27, 2026, 6:34 PM EST
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $290.04 million as of February 27, 2026. Its market cap has increased by 277.88% in one year.
Market Cap
290.04M
Enterprise Value
290.46M
1-Year Change
277.88%
Ranking
Category
Stock Price
$7.86
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $290.04M, a decrease of -47.60%. That is a compound annual growth rate of -23.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 288.93M | 451.41% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 305.66M |
| X4 Pharmaceuticals | 300.78M |
| Cellectis | 294.41M |
| Puma Biotechnology | 290.00M |
| Fennec Pharmaceuticals | 289.96M |
| AC Immune | 289.90M |
| Opus Genetics | 286.89M |
| Minerva Neurosciences | 285.61M |